Usefulness of plasma full‑length glypican‑3 as a predictive marker of hepatocellular carcinoma recurrence after radial surgery

• Published in: Oncology letters Vol. 19; no. 4; pp. 2657 - 2666
• Main Authors: Miura, Masahiro, Fujinami, Norihiro, Shimizu, Yasuhiro, Mizuno, Shoichi, Saito, Keigo, Suzuki, Toshihiro, Konishi, Masaru, Takahashi, Shinichiro, Gotohda, Naoto, Suto, Kouzou, Yoshida, Tomokazu, Nakatsura, Tetsuya
• Format: Journal Article
• Language: English
• Published: Greece Spandidos Publications 01.04.2020; Spandidos Publications UK Ltd; D.A. Spandidos
• Subjects: Biomarkers; Enzymes; Heparan sulfate; Hepatocellular carcinoma; Immunoassay; Liver cancer; Mass spectrometry; Medical prognosis; Medical research; Membranes; Methods; Oncology; Patients; Phosphatase; Prognosis; Proteins; Scientific imaging; Slovenia; Japan; glypican-3; protein induced by vitamin K absence or antagonist-II; alpha-fetoprotein; tumor marker; hepatocellular carcinoma

Predicting the risk of hepatocellular carcinoma (HCC) recurrence before treatment is necessary for developing subsequent treatment policies. Several tumor markers found in blood, such as alpha-fetoprotein (AFP) and protein induced by vitamin K absence or antagonist-II (PIVKA-II), are presently used...